Seeking Alpha

Affymetrix (AFFX -0.8%) says it's subsidiary, eBioscience, has sold its TrueBlot IP/Western blot...

Affymetrix (AFFX -0.8%) says it's subsidiary, eBioscience, has sold its TrueBlot IP/Western blot product line to Rockland Immunochemicals, a biotechnology company focusing on antibodies and antibody based tools for R&D and preclinical studies. TrueBlot reagents are used in Western blotting, a technique used in both scientific research and medical diagnosis to determine expression and quantitate target proteins in biological samples.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|